Enlivex Therapeutics
ENLV
ENLV
4 hedge funds and large institutions have $234K invested in Enlivex Therapeutics in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$36.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.11K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$86 |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $191K | +$36.8K | +2,325 | +24% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $38K | +$6.11K | +386 | +19% |
|
|
3
UBS Group
Zurich,
Switzerland
| $5K | +$86 | +5 | +2% |
|